VAD Implant Guideline Proposal Dubbed “One Year/One Block” Strategy
This article was originally published in The Gray Sheet
Executive Summary
Heart failure patients should be considered for ventricular assist device (VAD) implants when they can no longer walk at least one block or they have less than a year of life expectancy, according to Lynne Warner Stevenson, M.D., a cardiac surgeon at Brigham and Women's Hospital, Boston
You may also be interested in...
Thoratec HeartMate II Continuous-Flow LVAD Poses “Acceptable” Risks
A new study of Thoratec's HeartMate II continuous-flow left-ventricular assist device supports the growing consensus that patient selection has a far greater influence than device selection on the mortality rate of LVAD patients
INTERMACS Registry Will Light The Way To Earlier VAD Therapy – Editorial
The ongoing INTERMACS registry holds the key to expanding the usefulness of ventricular assist devices from just extending life to improving the quality of life, according to Lynne Warner Stevenson, cardiac surgeon at Brigham and Women's Hospital, Boston
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.